Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to 0.29.

  • Protagonist Therapeutics' Asset Utilization Ratio fell 4431.83% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year decrease of 4431.83%. This contributed to the annual value of 0.79 for FY2024, which is 29784.1% up from last year.
  • Per Protagonist Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.29 for Q3 2025, which was down 4431.83% from 0.28 recorded in Q2 2025.
  • In the past 5 years, Protagonist Therapeutics' Asset Utilization Ratio registered a high of 0.64 during Q4 2024, and its lowest value of 0.06 during Q3 2021.
  • Over the past 5 years, Protagonist Therapeutics' median Asset Utilization Ratio value was 0.28 (recorded in 2025), while the average stood at 0.3.
  • As far as peak fluctuations go, Protagonist Therapeutics' Asset Utilization Ratio skyrocketed by 484047.35% in 2021, and later tumbled by 7230.73% in 2023.
  • Protagonist Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.08 in 2021, then surged by 591.55% to 0.52 in 2022, then tumbled by 72.31% to 0.15 in 2023, then skyrocketed by 337.49% to 0.64 in 2024, then crashed by 54.9% to 0.29 in 2025.
  • Its Asset Utilization Ratio stands at 0.29 for Q3 2025, versus 0.28 for Q2 2025 and 0.27 for Q1 2025.